IMMUNOPHARMACODYNAMIC EVALUATION OF CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS

[1] ANDRUS L, 1982, SCAND J IMMUNOL, V15, P499

[2] BEVERIDGE T, 1980, CYCLOSPORIN CLIN EXP

[3] BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT [J]. AGENTS AND ACTIONS, 1976, 6 (04): : 468 - 475

[4] BUNJES D, 1981, EUROPEAN J IMMUNOLOG, V11, P656

[5] CALNE RY, 1978, LANCET, V2, P1323

[6] CUNNINGHAM C, 1983, TRANSPLANT P, V15, P2712

[7] Donatsch P, 1981, J Immunoassay, V2, P19, DOI 10.1080/01971528108062989

[8] DRATH DB, 1983, TRANSPLANT PROC, V15, P2369

[9] FERGUSON RM, 1983, TRANSPLANT P, V15, P535

[10] HESS AD, 1980, J IMMUNOL, V124, P2601

[1] ANDRUS L, 1982, SCAND J IMMUNOL, V15, P499

[2] BEVERIDGE T, 1980, CYCLOSPORIN CLIN EXP

[3] BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT [J]. AGENTS AND ACTIONS, 1976, 6 (04): : 468 - 475

[4] BUNJES D, 1981, EUROPEAN J IMMUNOLOG, V11, P656

[5] CALNE RY, 1978, LANCET, V2, P1323

[6] CUNNINGHAM C, 1983, TRANSPLANT P, V15, P2712

[7] Donatsch P, 1981, J Immunoassay, V2, P19, DOI 10.1080/01971528108062989

[8] DRATH DB, 1983, TRANSPLANT PROC, V15, P2369

[9] FERGUSON RM, 1983, TRANSPLANT P, V15, P535

[10] HESS AD, 1980, J IMMUNOL, V124, P2601